Houston, TX, United States of America

Ranjani Parthasarathy

This inventor holds 1 USPTO granted patent. Top assignee: Research Development Foundation. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ranjani Parthasarathy: Innovator in Chemotherapeutic Delivery Systems

Introduction

Ranjani Parthasarathy is a notable inventor based in Houston, TX (US). She has made significant contributions to the field of drug delivery systems, particularly in the optimization of chemotherapeutic agents for lung tissue.

Latest Patents

Ranjani holds a patent for "Liposomal aerosols for delivery of chemotherapeutic retinoids to the lungs." This innovative approach focuses on enhancing the delivery of all-trans retinoic acid (ATRA) to lung tissue. By utilizing liposomes, the method aims to minimize local irritation, reduce pulmonary toxicity, and maintain therapeutic levels of the drug. The research demonstrated that nebulization of L-ATRA effectively delivered high concentrations of the drug to the lungs of mice, with retention lasting up to 96 hours post-exposure. The aerosol-delivered ATRA was shown to be biologically active, indicating its potential for effective lung cancer treatment.

Career Highlights

Ranjani is associated with the Research Development Foundation, where she continues to explore innovative solutions in drug delivery. Her work has garnered attention for its potential to improve therapeutic outcomes in lung cancer patients.

Collaborations

Ranjani collaborates with esteemed colleagues, including Brian E. Gilbert and Kapil Mehta, to advance her research and develop effective treatment methodologies.

Conclusion

Ranjani Parthasarathy's contributions to the field of chemotherapeutic delivery systems highlight her innovative spirit and dedication to improving patient care. Her work exemplifies the impact of scientific research on medical advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…